These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22488365)

  • 1. Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients.
    Raϊch-Regué D; Grau-López L; Naranjo-Gómez M; Ramo-Tello C; Pujol-Borrell R; Martínez-Cáceres E; Borràs FE
    Eur J Immunol; 2012 Mar; 42(3):771-82. PubMed ID: 22488365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte-derived dendritic cells in multiple sclerosis: the effect of bacterial infection.
    Correale J; Farez M
    J Neuroimmunol; 2007 Oct; 190(1-2):177-89. PubMed ID: 17936916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis.
    Gross CC; Jonuleit H; Wiendl H
    Eur J Immunol; 2012 Mar; 42(3):569-72. PubMed ID: 22488360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial.
    Bar-Or A; Vollmer T; Antel J; Arnold DL; Bodner CA; Campagnolo D; Gianettoni J; Jalili F; Kachuck N; Lapierre Y; Niino M; Oger J; Price M; Rhodes S; Robinson WH; Shi FD; Utz PJ; Valone F; Weiner L; Steinman L; Garren H
    Arch Neurol; 2007 Oct; 64(10):1407-15. PubMed ID: 17698695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients.
    Elong Ngono A; Pettré S; Salou M; Bahbouhi B; Soulillou JP; Brouard S; Laplaud DA
    Clin Immunol; 2012 Aug; 144(2):117-26. PubMed ID: 22717772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell recognition of self-antigen presenting cells by protein transfer assay reveals a high frequency of anti-myelin T cells in multiple sclerosis.
    Bahbouhi B; Pettré S; Berthelot L; Garcia A; Elong Ngono A; Degauque N; Michel L; Wiertlewski S; Lefrère F; Meyniel C; Delcroix C; Brouard S; Laplaud DA; Soulillou JP
    Brain; 2010 Jun; 133(Pt 6):1622-36. PubMed ID: 20435630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by the activation of antigen-specific CD4+ CD25+ T-regulatory cells.
    Fu BM; He XS; Yu S; Hu AB; Ma Y; Wu LW; Tam NL; Huang JF
    Exp Clin Transplant; 2009 Sep; 7(3):149-56. PubMed ID: 19715524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice.
    Zhang GX; Yu S; Gran B; Li J; Calida D; Ventura E; Chen X; Rostami A
    J Neuroimmunol; 2004 Mar; 148(1-2):1-10. PubMed ID: 14975581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4⁺ T cell response to β2GPI.
    Torres-Aguilar H; Blank M; Kivity S; Misgav M; Luboshitz J; Pierangeli SS; Shoenfeld Y
    Ann Rheum Dis; 2012 Jan; 71(1):120-8. PubMed ID: 21914629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance.
    Zhou Y; Leng X; Luo S; Su Z; Luo X; Guo H; Mo C; Zou Q; Liu Y; Wang Y
    J Immunol Res; 2016; 2016():5021537. PubMed ID: 28070525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific T-cell proliferation to myelin peptides in relapsing-remitting multiple sclerosis.
    Grau-López L; Raïch D; Ramo-Tello C; Naranjo-Gómez M; Dávalos A; Pujol-Borrell R; Borràs FE; Martínez-Cáceres E
    Eur J Neurol; 2011 Aug; 18(8):1101-4. PubMed ID: 21749576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell vaccination in multiple sclerosis relapsing-remitting nonresponders patients.
    Achiron A; Lavie G; Kishner I; Stern Y; Sarova-Pinhas I; Ben-Aharon T; Barak Y; Raz H; Lavie M; Barliya T; Faibel M; Cohen IR; Mandel M
    Clin Immunol; 2004 Nov; 113(2):155-60. PubMed ID: 15451472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
    Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
    J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis.
    Schinnerling K; Soto L; García-González P; Catalán D; Aguillón JC
    Autoimmun Rev; 2015 Jun; 14(6):517-27. PubMed ID: 25633325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory Effects of 1,25-Dihydroxyvitamin D
    Lee WP; Willekens B; Cras P; Goossens H; Martínez-Cáceres E; Berneman ZN; Cools N
    J Immunol Res; 2016; 2016():5392623. PubMed ID: 27703987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Fas antigen on T cell subpopulations in peripheral blood of patients with relapsing-remitting multiple sclerosis.
    Bilińska M; Frydecka I; Podemski R; Teodorowska R; Gruszka E
    Med Sci Monit; 2001; 7(2):251-5. PubMed ID: 11257731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerogenic dendritic cells induce antigen-specific hyporesponsiveness in insulin- and glutamic acid decarboxylase 65-autoreactive T lymphocytes from type 1 diabetic patients.
    Segovia-Gamboa N; Rodríguez-Arellano ME; Rangel-Cruz R; Sánchez-Díaz M; Ramírez-Reyes JC; Faradji R; González-Domínguez É; Sánchez-Torres C
    Clin Immunol; 2014 Sep; 154(1):72-83. PubMed ID: 24993292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells.
    Dáňová K; Grohová A; Strnadová P; Funda DP; Šumník Z; Lebl J; Cinek O; Průhová Š; Koloušková S; Obermannová B; Petruželková L; Šedivá A; Fundová P; Buschard K; Špíšek R; Palová-Jelínková L
    J Immunol; 2017 Jan; 198(2):729-740. PubMed ID: 27927966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.